Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

T
Tabatabai, Ghazaleh

Department for Neurology & Neuro-Oncology, University Hospital Tübingen and Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Ghazaleh Tabatabai
Favorite
Taebi, Arshia

Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Arshia Taebi
Favorite
Takahashi, Mitsuru

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Mitsuru Takahashi
Favorite
Takemori, Toshiyuki

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Toshiyuki Takemori
Favorite
Takenaka, Satoshi

Osaka International Cancer Institute
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Satoshi Takenaka
Favorite
Tala, Ilona

Servier
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Ilona Tala
Favorite
Talbot, Lindsay

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Lindsay Talbot
Favorite
Tamamyan, Gevorg

Yerevan State Medical University
(P 158) GLOBAL INEQUITIES IN CHONDROSARCOMA CLINICAL TRIALS: A COMPREHENSIVE ANALYSIS ACROSS THREE DECADES
Gevorg Tamamyan
Favorite
Tanaka, Kazuhiro

Oita University
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Kazuhiro Tanaka
Favorite
Tanaka, Yutaro

Dana-Farber Cancer Institute
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Yutaro Tanaka
Favorite
Tan, Chia Jie

Department of Pharmacotherapy, College of Pharmacy, University of Utah
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Chia Jie Tan
Favorite
Tang, Chih-Min

Dept. of Surgery, Moores Cancer Center, University of California San Diego
(P 197) DIFFERENTIAL EFFECTS OF ANAGRELIDE IN GASTROINTESTINAL STROMAL TUMORS (GIST) IN VITRO
Chih-Min Tang
Favorite
TANG, XIAO DONG

Peking University People's Hospital
(P 74) TERTIARY LYMPHOID STRUCTURES PREDICT PROGNOSIS AND IMMUNE LANDSCAPE IN OSTEOSARCOMA: A MACHINE LEARNING-BASED TRANSCRIPTOMIC STUDY
XIAO DONG TANG
Favorite
Tang, Xiaodong

Musculoskeletal Tumor Centre, Peking University People's Hospital
(P 75) CD248 AS A PROGNOSTIC MARKER IN OSTEOSARCOMA
Xiaodong Tang
Favorite
Tan, Li

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Li Tan
Favorite
Tan, Lisa

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Lisa Tan
Favorite
Tan, Marcus

Vanderbilt University Medical Center
(P 310) ATYPICAL SPINDLE CELL PLEOMORPHIC LIPOMATOUS TUMORS OF THE RETROPERITONEUM ARE HETEROGENOUS: A REPORT OF FOUR DISPARATE CASES
Marcus Tan
Favorite
Tanwar, Puneet

All India Institute of Medical Sciences, New Delhi
(P 276) RADIATION-INDUCED SARCOMA (RIS): CLINICAL SPECTRUM AND ONCOLOGIC OUTCOMES FROM A TERTIARY INDIAN SARCOMA CLINIC
Puneet Tanwar
Favorite
Tao, Wensi

University of Miami
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Wensi Tao
Favorite
Tap, William

Memorial Sloan Kettering Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
William Tap
Favorite
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
William Tap
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
William Tap
Favorite
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
William Tap
Favorite
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
William Tap
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
William Tap
Favorite
(P 430) A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
William Tap
Favorite
(P 467) TREATMENT OUTCOMES IN AGGRESSIVE ANGIOMYXOMA: A SINGLE INSTITUTION EXPERIENCE
William Tap
Favorite
Taqi, Kadhim

Arthur Child Cancer Center
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Kadhim Taqi
Favorite
Taroni, Jaclyn

Alex's CC Data Lab
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Jaclyn Taroni
Favorite
Taslim, Cenny

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Cenny Taslim
Favorite
Taswell, Crystal

University of Miami, Department of Radiation Oncology
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Crystal Taswell
Favorite
Tattersall, Luke

The University of Sheffield
(P 136) ESTROGEN HAS A PROTECTIVE EFFECT ON CHONDROSARCOMA GROWTH IN VITRO AND IN VIVO
Luke Tattersall
Favorite
Taverna, Silvia

Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Silvia Taverna
Favorite
Tawbi, Hussein

M.D. Anderson Cancer Center, Houston
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Hussein Tawbi
Favorite
Taylor-Black, Quinn

Massachusetts General Hospital
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Quinn Taylor-Black
Favorite
Tay, Timothy Kwang Yong

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Timothy Kwang Yong Tay
Favorite
Tecson, Kristen

Evidence Generation, Daiichi Sankyo, Inc., Basking Ridge, NJ, USA
(P 336) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 5-YEAR RETROSPECTIVE HEPATIC SAFETY ASSESSMENT
Kristen Tecson
Favorite
Tedesco, Nicholas

Western University of Health Sciences
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Nicholas Tedesco
Favorite
Teicher, Beverly

National Cancer Institute
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Beverly Teicher
Favorite
Temple, H.T.

1.University of Miami , Miller School of Medicine, Department of Orthopedic Surgery
(P 31) TARGETING CANCER STEM CELLS BY TYROSINE PEPTIDE ANALOGUE IN REFRACTORY SARCOMA
H.T. Temple
Favorite
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
H.T. Temple
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
H.T. Temple
Favorite
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
H.T. Temple
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
H.T. Temple
Favorite
Tepper, Sarah

Moffitt Cancer Center
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Sarah Tepper
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Sarah Tepper
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Sarah Tepper
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Sarah Tepper
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Sarah Tepper
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Sarah Tepper
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Sarah Tepper
Favorite
Terés Lleida, Raúl

Hospital Santa Creu i Sant Pau
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Raúl Terés Lleida
Favorite
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Raúl Terés Lleida
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Raúl Terés Lleida
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Raúl Terés Lleida
Favorite
Terrasi, Andrea

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Andrea Terrasi
Favorite
Tesselaar, Margot

The Netherlands Cancer Institute
(P 444) HEALTH-RELATED QUALITY OF LIFE (HRQOL) CHALLENGES IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): ANALYSIS OF AN ULTRA-RARE SARCOMA GROUP
Margot Tesselaar
Favorite
Teterycz, Pawel

Maria Sklodowska-Curie National Research Institute of Oncology
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Pawel Teterycz
Favorite
(P 149) SURGICAL TEXTBOOK OUTCOMES IN PATIENTS DIAGNOSED WITH CHONDROSARCOMA
Pawel Teterycz
Favorite
(P 313) SIGNIFICANCE OF LYMPH NODE PROCEDURES IN SOFT TISSUE SARCOMA PATIENTS
Pawel Teterycz
Favorite
(P 470) OFF-LABEL TREATMENT AND ULTRARARE SARCOMAS - SINGLE INSTITUTION REPORT
Pawel Teterycz
Favorite
Teuber, Alina

MSKCC
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Alina Teuber
Favorite
Thacker, Christine

UCSF Helen Diller Family Comprehensive Cancer Center
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Christine Thacker
Favorite
Thakur, rudra Pratap

Balco
(P 103) EARLY OUTCOMES OF BONE PROSTHESIS COMPOSITE FOR RECONSTRUCTION IN LOWER LIMB TUMORS. A SINGLE INSTITUTION STUDY
rudra Pratap Thakur
Favorite
Theisen, Emily

Nationwide Children's Hospital
(P 23) DEFINING THE NONENZYMATIC FUNCTIONS OF LSD1 IN EWING SARCOMA
Emily Theisen
Favorite
Thiels, Cornelius

Mayo Clinic
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Cornelius Thiels
Favorite
Thierauf, Julia

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Julia Thierauf
Favorite
Thirasastr, Prapassorn

The University of Texas MD Anderson Cancer Center
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Prapassorn Thirasastr
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Prapassorn Thirasastr
Favorite
(P 274) RACIAL DISPARITIES IN INCIDENCE AND MORTALITY OVER 20 YEARS AMONG AYA PATIENTS WITH SARCOMA IN THE US: A SEER DATABASE ANALYSIS
Prapassorn Thirasastr
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Prapassorn Thirasastr
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Prapassorn Thirasastr
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Prapassorn Thirasastr
Favorite
Thng, Dexter Kai Hao

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Dexter Kai Hao Thng
Favorite
Thomas, David

Centre for Molecular Oncology
(P 49) GENETIC INTERACTION BETWEEN SPRED3 AND SMARCB1 CAUSES EXPLOSIVE MULTIFOCAL MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
David Thomas
Favorite
Thomas, Shari

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Shari Thomas
Favorite
Thomas, Stefanie

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Stefanie Thomas
Favorite
Thompson, Austen

Mayo Clinic
(P 96) AMPUTATION FOLLOWING MEGAPROSTHESIS USE IN LIMB SALVAGE
Austen Thompson
Favorite
(P 150) LOCAL RECURRENCE OF CHONDROSARCOMA: IMPACT ON SURVIVAL AND RECURRENCE AT AN INCREASED GRADE
Austen Thompson
Favorite
(P 348) SYNOVIAL SARCOMA INVOLVING NERVES: HIGH RATE OF MISIDENTIFICATION AS BENIGN TUMORS
Austen Thompson
Favorite
Thompson, Marshall

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Marshall Thompson
Favorite
Thompson, Matthew

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Matthew Thompson
Favorite
Thompson, Wayne

Nationwide Children's Hospital
(P 377) GERMLINE RECQL4 VARIANT IN A PEDIATRIC PATIENT WITH EWING SARCOMA AND DESMOID FIBROMATOSIS
Wayne Thompson
Favorite
Thorkildsen, Joachim

Oslo University Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Joachim Thorkildsen
Favorite
Thornell, Anders

Institute of Clinical Sciences/Sahlgrenska Academy
(P 124) ISOLATED LIMB PERFUSION AS LIMB SALVAGING TREATMENT; A SINGLE CENTRE RETROSPECTIVE STUDY
Anders Thornell
Favorite
Thornton, Mason

University of Miami Miller School of Medicine
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Mason Thornton
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Mason Thornton
Favorite
Thorpe, Steven

University of Colorado Department of Orthopedics
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Steven Thorpe
Favorite
Thorpe, Steven

Orthopedic Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Steven Thorpe
Favorite
Thorpe, Steven

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Steven Thorpe
Favorite
Thway, Khin

The Royal Marsden NHS Foundation Trust
(P 414) PATTERNS OF RELAPSE OF BORDERLINE AND MALIGNANT PHYLLODES TUMOUR- RESULTS FROM SARCOMA REFERENCE CENTRE (SRC)
Khin Thway
Favorite
Tian, Kai

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Kai Tian
Favorite
Timmermann, Beate

West German Proton Therapy Centre Essen
(P 250) OUTCOME OF INFANTS WITH RHABDOMYOSARCOMA: A REPORT FROM THE INTERNATIONAL SOFT TISSUE SARCOMA CONSORTIUM
Beate Timmermann
Favorite
Tinè, Gabriele

Fondazione IRCCS Istituto Nazionale dei Tumori, Mialno
(P 331) MAINTENANCE THERAPY (M-TP) WITH DACARBAZINE (DTIC) AFTER FIRST-LINE ANTHRACYCLINE-BASED DOUBLET IN ADVANCED LEIOMYOSARCOMA (LMS) PATIENTS (PTS): OUTCOMES OF A CASE SERIES IN A SINGLE REFERRAL CENTER
Gabriele Tinè
Favorite
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Gabriele Tinè
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Gabriele Tinè
Favorite
Tin, Antony

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Antony Tin
Favorite
Tinoco, Gabriel

The Ohio State University Comprehensive Cancer Center
(P 128) ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATION TESTING IN THE PHASE 3 STUDY OF IVOSIDENIB VS PLACEBO IN IDH1-MUTANT CONVENTIONAL CHONDROSARCOMA (CHONQUER)
Gabriel Tinoco
Favorite
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
Gabriel Tinoco
Favorite
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
Gabriel Tinoco
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
Gabriel Tinoco
Favorite
Tipping, Alex

Adaptimmune
(P 247) SINGLE-CELL RNA SEQUENCING OF AFAMITRESGENE AUTOLEUCEL INDICATES MECHANISMS OF PERSISTENCE AND ANTI-TUMOR ACTIVITY
Alex Tipping
Favorite
Tipps, Megan

Parabilis Medicines
(P 415) A PHASE 1/2 TRIAL OF FOG-001, A FIRST-IN-CLASS DIRECT β-CATENIN:TCF4 INHIBITOR: SAFETY AND PRELIMINARY ANTITUMOR ACTIVITY IN PATIENTS WITH DESMOID TUMORS (DT)
Megan Tipps
Favorite
Toda, Yu

National Cancer Center Hospital
(P 159) CHONDROSARCOMA IN JAPAN: A POPULATION-BASED ANALYSIS USING NATIONAL CANCER REGISTRY
Yu Toda
Favorite
Todi, Niket

UC Davis Health
(P 95) COMPARATIVE OUTCOMES OF OPERATIVE AND NON-OPERATIVE TREATMENT FOR METASTATIC HUMERAL PATHOLOGIC FRACTURES
Niket Todi
Favorite
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Niket Todi
Favorite
(P 349) THE COST OF SURVEILLANCE IN CALIFORNIA: MRI UTILIZATION IN RECURRENT EXTREMITY SOFT TISSUE SARCOMA
Niket Todi
Favorite
(P 360) MRI SURVEILLANCE PRACTICES AND RECURRENCE DETECTION IN EXTREMITY SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY
Niket Todi
Favorite
Toh, Tan Boon

National University of Singapore
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Tan Boon Toh
Favorite
Toki, Shunichi

Shizuoka Cancer Center
(P 291) INTRA-ARTERIAL CHEMOTHERAPY WITH CONCOMITANT RADIATION THERAPY FOR UNRESECTABLE SARCOMA
Shunichi Toki
Favorite
Toledano, Helen

Schneider Children's Medical Center, Petah Tikva, Israel
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Helen Toledano
Favorite
Tolomeo, Francesco

Oncology Unit, Candiolo Cancer Institute, FPO – IRCCS
(P 231) INCREASED LIFETIME RISK (LTR) OF SOFT TISSUE SARCOMAS (STS) IN PATIENTS WITH LOW-RISK GASTROINTESTINAL STROMAL TUMORS (GIST): A RETROSPECTIVE ANALYSIS FROM THE ITALIAN SARCOMA GROUP (ISG)
Francesco Tolomeo
Favorite
Tomassoni, Lorenzo

Columbia University Irving Medical Center
(P 25) IDENTIFICATION AND VALIDATION OF NON-GENETICALLY ENCODED VULNERABILITIES IN EWING SARCOMA
Lorenzo Tomassoni
Favorite
Tomkinson, Blake

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Blake Tomkinson
Favorite
Tonini, Giuseppe

Fondazione Policlinico Universitario Campus Bio-Medico
(P 61) HER2 TARGETING IN CHORDOMA: PRECLINICAL INSIGHTS ON TRASTUZUMAB DERUXTECAN
Giuseppe Tonini
Favorite
Topf, Michael

Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Michael Topf
Favorite
Torner Marchessi, Elena

Hospital Universitario de Toledo
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Elena Torner Marchessi
Favorite
(P 385) PROGNOSTIC IMPACT OF PERIPHERAL BLOOD CELL RATIO VALUES IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: A REFERENCE CENTER EXPERIENCE.
Elena Torner Marchessi
Favorite
Torralbas Fitz, Sergio

University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Sergio Torralbas Fitz
Favorite
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Sergio Torralbas Fitz
Favorite
Torres, Keila

MD Anderson Cancer Center
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Keila Torres
Favorite
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Keila Torres
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Keila Torres
Favorite
Torrezan, Giovana T.

AC Camargo Cancer Center
(P 132) MOLECULAR LANDSCAPE AND CLINICAL HETEROGENEITY OF BRAZILIAN CHONDROSARCOMAS: INSIGHTS FROM IDH, TERT, AND GENOME-WIDE ANALYSIS
Giovana T. Torrezan
Favorite
(P 137) GENOMIC ALTERATIONS IN RARE CARTILAGINOUS TUMOR SYNDROMES ASSOCIATED WITH CHONDROSARCOMA DEVELOPMENT
Giovana T. Torrezan
Favorite
(P 155) BRCA2-MUTATED CONVENTIONAL CHONDROSARCOMA RESPONDING TO PARP INHIBITION: A CASE REPORT
Giovana T. Torrezan
Favorite
Torsello, Monica

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Monica Torsello
Favorite
Toureille, Maîlys

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
Maîlys Toureille
Favorite
Towler, Jonathan

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Jonathan Towler
Favorite
Town, Ajia

OHSU Knight Cancer Institute
(P 182) USING IN VITRO MODELS TO PREDICT IMATINIB RESPONSES OF PDGFRA EXON 18-MUTANT GIST
Ajia Town
Favorite
Tram, Nam
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Nam Tram
Favorite
Travis, Levi

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Levi Travis
Favorite
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Levi Travis
Favorite
Travis, Levi

University of Miami
(P 99) LIMB SALVAGE FOR PROXIMAL TIBIA TUMORS: OUTCOMES OF ALLOGRAFT-PROSTHESIS COMPOSITE AND ENDOPROSTHETIC RECONSTRUCTION
Levi Travis
Favorite
Trenholm, Ryan

Nova Scotia Health Authority
(P 143) IMPACT OF SURGICAL MARGINS IN CHEST WALL CHONDROSARCOMAS: A CANSARCC STUDY
Ryan Trenholm
Favorite
Trent, Jonathan

Sarcoma Medical Research Program, University of Miami – Sylvester Comprehensive Cancer Center
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Jonathan Trent
Favorite
(P 131) GLUCOSE TRANSPORTER 1 (GLUT1) INHIBITION DECREASES THE GROWTH AND PROLIFERATION OF CHONDROSARCOMA
Jonathan Trent
Favorite
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Jonathan Trent
Favorite
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jonathan Trent
Favorite
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Jonathan Trent
Favorite
(P 217) PATIENT QUESTIONNAIRE EXPLORING THE PRE-SARCOMA DIAGNOSIS CHARACTERISTICS OF SARCOMA PATIENTS
Jonathan Trent
Favorite
(P 224) PAN-SARCOMA DATABASE (PSDB): AN UPDATE ON MIAMI'S COLLABORATIVE MULTI-USER DATA PIPELINE OF SARCOMA DATA USING REDCAP AND R CODING
Jonathan Trent
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
Jonathan Trent
Favorite
(P 289) SIX YEAR FOLLOW-UP ON CIVASHEET® USE FOR SOFT TISSUE SARCOMA: A SINGLE INSTITUTION EXPERIENCE
Jonathan Trent
Favorite
(P 320) CLINICAL CHARACTERISTICS AND RECURRENCE PATTERNS IN HISPANIC VS. NON-HISPANIC PATIENTS WITH LEIOMYOSARCOMA: FINDINGS FROM A RETROSPECTIVE SINGLE-CENTER COHORT STUDY
Jonathan Trent
Favorite
(P 327) INITIAL TREATMENT MODALITY AND RECURRENCE IN NON-METASTATIC LEIOMYOSARCOMA: A RETROSPECTIVE COHORT STUDY
Jonathan Trent
Favorite
(P 333) METABOLIC SYNDROME CORRELATION WITH LIPOSARCOMA INCIDENCE AND OUTCOMES: A RETROSPECTIVE ANALYSIS.
Jonathan Trent
Favorite
(P 362) SHOULD PAZOPANIB BE USED AS A MAINTENANCE THERAPY TO IMPROVE RECURRENCE-FREE SURVIVAL AND OVERALL SURVIVAL IN PATIENTS WHO RECEIVED MAI IN SOFT TISSUE SARCOMA?
Jonathan Trent
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
Jonathan Trent
Favorite
(P 397) EXPLORING REAL WORLD DATA OF RECURRENCE IN NON-METASTATIC MYXOFIBROSAROMA: AN UPDATED RETROSPECTIVE COHORT STUDY
Jonathan Trent
Favorite
(P 403) MEDICAL MANAGEMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Jonathan Trent
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Jonathan Trent
Favorite
(P 424) AN OPEN-LABEL PHASE 1/2 STUDY OF DCC-3009 MONOTHERAPY IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST)
Jonathan Trent
Favorite
Trickett, Justin

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Justin Trickett
Favorite
Troulis, Maria

Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Maria Troulis
Favorite
Trucco, Matteo

Cleveland Clinic
(P 284) THE IMPACT OF SARCOMA SBRT ON THE IMMUNE SYSTEM: EARLY RESULTS FROM A PROSPECTIVE TRIAL
Matteo Trucco
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Matteo Trucco
Favorite
Truong, Danh

MD Anderson Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Danh Truong
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Danh Truong
Favorite
Tsai, Hui-Jen

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Hui-Jen Tsai
Favorite
Tseng, William

City of Hope National Medical Center
(P 307) STRATEGIES FOR DATA QUALITY IN TARPSWG RETROPERITONEAL SARCOMA REGISTRY (RESAR)
William Tseng
Favorite
(P 308) IMPACT OF PSOAS MUSCLE RESECTION ON OUTCOMES IN PRIMARY RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
William Tseng
Favorite
(P 309) RETROPERITONEAL LIPOMAS: MULTICENTER CLINICAL EXPERIENCE WITH AN EXTREMELY RARE DISEASE ENTITY
William Tseng
Favorite
(P 452) EFFECTIVENESS OF ERIBULIN FOR MYXOID PLEOMORPHIC LIPOSARCOMA: INSIGHTS FROM A PATIENT-DERIVED MODEL AND CLINICAL TRANSLATION IN A PATIENT WITH ADVANCED DISEASE
William Tseng
Favorite
Tsoi, Kim

Department of Surgery, Sinai Health
(P 55) THE EFFECT OF STAT1 Y701 PHOSPHORYLATION ON GENE EXPRESSION IN UPS
Kim Tsoi
Favorite
(P 88) THE RAY CHALLENGE: HOW MANY RAY RESECTIONS CAN PATIENTS TOLERATE AND WHICH RAY RESECTIONS AFFECTS FUNCTIONAL OUTCOME THE MOST IN ORTHOPEDIC ONCOLOGY?
Kim Tsoi
Favorite
(P 323) EVALUATION OF COSMIC MUTATIONAL SIGNATURES IN SOFT TISSUE SARCOMA
Kim Tsoi
Favorite
(P 332) MARGINAL EXCISION OF EXTREMITY DEDIFFERENTIATED LIPOSARCOMA WITHOUT RADIATION MAY BE SAFE IN SELECT PATIENTS
Kim Tsoi
Favorite
(P 374) DISTINCT PATTERNS OF METASTATIC SPREAD IN LEIOMYOSARCOMA: A COMPARATIVE ANALYSIS OF TRUNCAL AND EXTREMITY TUMOURS
Kim Tsoi
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Kim Tsoi
Favorite
Tsuchiya, Karen

Steve and Cindy Rasmussen Institute for Genomic Medicine, The Abigail Wexner Research Institute, Nationwide Children’s Hospital
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Karen Tsuchiya
Favorite
Tumminello, Brad

Springworks Therapeutics, Inc.
(P 357) DEVELOPMENT OF AN ALGORITHM TO IDENTIFY PATIENTS (PT) WITH DESMOID TUMORS (DT) IN A UNITED STATES (US) CLAIMS DATASET
Brad Tumminello
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Brad Tumminello
Favorite
(P 368) ASSESSMENT OF PAIN DIAGNOSIS AND PAIN MEDICATION USE IN ADULTS TREATED WITH NIROGACESTAT: A UNITED STATES REAL-WORLD ANALYSIS
Brad Tumminello
Favorite
Tuohy, Joanne

Virginia-Maryland Regional College of Veterinary Medicine
(P 259) PRECLINICAL MODELING OF CHEMOTHERAPY RELEASE IDENTIFIES MITOCHONDRIAL ADAPTATIONS IN DOXORUBICIN TREATED OSTEOSARCOMA
Joanne Tuohy
Favorite
turcotte, Robert

McGill university and RI-MUHC
(P 15) EZHIP: A NOVEL EPIGENETIC DRIVER OF OSTEOSARCOMA PATHOGENESIS
Robert turcotte
Favorite
Tuziak, Justyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Justyna Tuziak
Favorite
Tysarowski, Andrzej

Cancer Molecular and Genetic Diagnostics Laboratory, Maria Sklodowska-Curie National Research Institute of Oncology
(P 27) MOLECULAR CHARACTERIZATION OF RESPONSE TO NEOADJUVANT CHEMORADIATION IN PATIENTS WITH LOCALLY ADVANCED SOFT TISSUE SARCOMAS
Andrzej Tysarowski
Favorite
(P 139) IMMUNOGENOMIC PROFILING OF CHONDROSARCOMA REVEALS DISTINCT IMMUNE PHENOTYPES AND PROGNOSTIC MUTATIONS
Andrzej Tysarowski
Favorite